Relationship between hyperuricemia and chronic kidney disease

Nucleosides, Nucleotides and Nucleic Acids

Volumn 30, Issue 12, 2011, Pages 1039-1044

  Ohno, Iwao ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic kidney disease; Hypertension; Hyperuricemia; Uric acid

Indexed keywords

ALLOPURINOL; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTICLE; BLOOD PRESSURE MEASUREMENT; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; HYPERTENSION; HYPERURICEMIA; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY INJURY; METABOLIC SYNDROME X; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; TREATMENT OUTCOME;

GLOMERULONEPHRITIS, IGA; HUMANS; HYPERTENSION; HYPERURICEMIA; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; METABOLIC SYNDROME X; MODELS, BIOLOGICAL; TIME FACTORS; URIC ACID;

EID: 84855873905     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770.2011.611484     Document Type: Article

References (14)

1. Perlstein, T. S.; Gumieniak, O.; Williams, G. H.; Sparrow, D.; Vokonas, P. S.; Gaziano, M.; Weiss, S. T.; Litonjua, A. A. Uric acid and the development of hypertension: the normative aging study. Hypertension 2006, 48, 1031-1036. (Pubitemid 44772704)
2. Zhang, W.; Sun, K.; Yang, Y.; Zhang, H.; Hu, F. B.; Hui, R. Plasma uric acid and hypertension in a Chinese community: prospective study and meta-analysis. Clin. Chem. 2009, 55, 2026-2034.
3. Feig, D. I.; Soletsky, B.; Johnson, R. J. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA 2008, 300, 924-932.
4. Iseki, K.; Oshiro, S.; Tozawa, M.; Iseki, C.; Ikemiya, Y.; Takishita, S. Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hypertens Res. 2001, 24, 691-697. (Pubitemid 33133783)
5. Iseki, K.; Ikemiya, Y.; Inoue, T.; Iseki, C.; Kinjo, K.; Takishita, S. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am. J. Kidney Dis. 2004, 44, 642-650. (Pubitemid 39237608)
6. Tomita, M.; Mizuno, S.; Yamanaka, H.; Hosoda, Y.; Sakuma, K.; Matuoka, Y.; Odaka, M.; Yamaguchi, M.; Yosida, H.; Morisawa, H.; Murayama, T. Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers. J. Epidemiol. 2000, 10, 403-409.
7. Obermayr, R. P.; Temml, C.; Gutjahr, G.; Knechtelsdorfer, M.; Oberbauer, R.; Klauser-Braun, R. Elevated uric acid increases the risk for kidney disease. J. Am. Soc. Nephrol. 2008, 19, 2407-2413.
8. Ohno, I.; Hosoya, T.; Gomi, H.; Ichida, K.; Okabe, H.; Hikita, M. Serum uric acid and renal prognosis in patients with IgA nephropathy. Nephron. 2001, 87, 333-339. (Pubitemid 32260834)
9. Kanbay, M.; Ozkara, A.; Selcoki, Y.; Isik, B.; Turgut, F.; Bavbek, N.; Uz, E.; Akcay, A.; Yigitoglu, R.; Covic, A. Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearance, and proteinuria in patients with normal renal functions. Int. Urol. Nephrol. 2007, 39, 1227-1233. (Pubitemid 350193621)
10. Siu, Y. P.; Leung, K. T.; Tong, M. K.; Kwan, T. H. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am. J. Kidney Dis. 2005, 47, 51-59. (Pubitemid 41828266)
11. Talaat, K. M.; El-Sheikh, A. R. The effect of mild hyperuricemia on urinary transforming growth factor beta and the progression of chronic kidney disease. Am. J. Nephrol. 2007, 27, 435-440. (Pubitemid 47481999)
12. Hikita, M.; Ohno, I.; Mori, Y.; Ichida, K.; Yokose, T.; Hosoya, T. Relationship between hyperuricemia and body fat distribution. Internal Medicine 2007, 46, 1353-1358. (Pubitemid 47455757)
13. Abate, N.; Chandalia, M.; Cabo-Chan, A. V., Jr; Moe, O. W.; Sakhaee, K. The metabolic syndrome and uric acid nephrolithiasis: Novel features of renal manifestation of insulin resistance. Kidney Int. 2004, 65, 386-392. (Pubitemid 38130632)
14. Tsuji, H.; Miyagawa, M.; Arimoto, S.; Sha, K.; Nakajima, H.; Hara, S. The relationship of uric acid and urinary pH to metabolic syndrome and its defining factors. Ningendock 2007, 22, 383-388. (in Japanese)